After a series of negotiations, British drugmaker AstraZeneca has finally signed a Memorandum of Intent with Russia's Gamaleya Institute, which developed Sputnik V, Russia's RDIF sovereign wealth fund, and Russian drugmaker R-Pharm.
The memorandum allows for joint efforts to find sustainable solution to the coronavirus...
AstraZeneca Signs Memorandum With Gamaleya Centre, RDIF And R-Pharm
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Russia could twist a few arms in the West with the help of Sputnik V vaccine
The cooperation between Russia's Gamaleya Center and AstraZeneca transnational company will change the perception of Russia in the..
PRAVDA